Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.

about

Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.

Item

http://www.wikidata.org/entity/Q39949574

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Evaluation of efficacy and saf ...... n a Latin American population.

@en

Evaluation of efficacy and saf ...... n a Latin American population.

@nl

type

Item

label

Evaluation of efficacy and saf ...... n a Latin American population.

@en

Evaluation of efficacy and saf ...... n a Latin American population.

@nl

prefLabel

Evaluation of efficacy and saf ...... n a Latin American population.

@en

Evaluation of efficacy and saf ...... n a Latin American population.

@nl

P1476

Evaluation of efficacy and saf ...... n a Latin American population.

@en

P2093

B S Komm

http://www.w3.org/2001/XMLSchema#string

J Lavenberg

http://www.w3.org/2001/XMLSchema#string

K Pan

http://www.w3.org/2001/XMLSchema#string

L Arias

http://www.w3.org/2001/XMLSchema#string

S Mirkin

http://www.w3.org/2001/XMLSchema#string

S Palacios

http://www.w3.org/2001/XMLSchema#string

P2860

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.

Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.

Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes.

Major cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO)

Latin American position on the current status of hormone therapy during the menopausal transition and thereafter.

A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.

Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis.

Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.

Age of menopause and impact of climacteric symptoms by geographical region.

P304

261-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13697137.2016.1146248

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26940720

http://www.w3.org/2001/XMLSchema#string